Overview
Also known as:
FDA & Trial Timeline
10 eventsGuangzhou Novaken Pharm Co., Ltd. — PHASE2
Cochlear
Al-Azhar University — PHASE3
University of Arizona — PHASE1, PHASE2
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
No FDA-approved treatments are currently listed for X-linked immune dysregulation with inflammatory bowel disease due to ELF4 deficiency.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for X-linked immune dysregulation with inflammatory bowel disease due to ELF4 deficiency at this time.
New trials open frequently. Follow this disease to get notified.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Financial Resources
1 resourcesDoxycycline
Pfizer
Rosacea
Travel Grants
No travel grants are currently matched to X-linked immune dysregulation with inflammatory bowel disease due to ELF4 deficiency.
Community
No community posts yet. Be the first to share your experience with X-linked immune dysregulation with inflammatory bowel disease due to ELF4 deficiency.
Start the conversation →Latest news about X-linked immune dysregulation with inflammatory bowel disease due to ELF4 deficiency
Disease timeline:
New recruiting trial: Isatuximab, Bela Maf, Pom, and Dex in Relapsed/Refractory Multiple Myeloma
A new clinical trial is recruiting patients for X-linked immune dysregulation with inflammatory bowel disease due to ELF4 deficiency
New recruiting trial: The Study is Being Conducted to Evaluate the Efficacy and Safety of Dexmedetomidine Hydrochloride Microneedles for Preoperative Sedation in Children
A new clinical trial is recruiting patients for X-linked immune dysregulation with inflammatory bowel disease due to ELF4 deficiency
New recruiting trial: Dex +/- Caffeine Sedation in a Post-MRI Recovery in a Pediatric Population
A new clinical trial is recruiting patients for X-linked immune dysregulation with inflammatory bowel disease due to ELF4 deficiency
New recruiting trial: Long-term Follow-up of a Cochlear Implant With Dexamethasone Eluting Electrode Array
A new clinical trial is recruiting patients for X-linked immune dysregulation with inflammatory bowel disease due to ELF4 deficiency
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about X-linked immune dysregulation with inflammatory bowel disease due to ELF4 deficiency
Which specialists treat X-linked immune dysregulation with inflammatory bowel disease due to ELF4 deficiency?
3 specialists and care centers treating X-linked immune dysregulation with inflammatory bowel disease due to ELF4 deficiency are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.
What treatment and support options exist for X-linked immune dysregulation with inflammatory bowel disease due to ELF4 deficiency?
1 patient support program are currently tracked on UniteRare for X-linked immune dysregulation with inflammatory bowel disease due to ELF4 deficiency. See the treatments and support programs sections for copay assistance, eligibility, and contact details.